Gang Wang | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Gang Wang | AI in Healthcare | Best Researcher Award

Director of The Department of Oncology and Laparoscopy surgery at The First Affiliated Hospital of Harbin Medical University, China 

Dr. Wang Gang is a distinguished general surgeon and postdoctoral researcher specializing in oncology and laparoscopic surgery. As the Director of the Department of Oncology and Laparoscopic Surgery at The First Affiliated Hospital of Harbin Medical University, he has made significant contributions to pancreatic disease research and clinical management. Recognized as a High-Level Talent of Heilongjiang Province, Dr. Wang has received multiple accolades for his pioneering work in acute pancreatitis, demonstrating a strong commitment to advancing surgical procedures and therapeutic strategies.

Profile

Scholar

Education

Dr. Wang earned his medical degree (MD) and doctoral degree (Ph.D.) from Harbin Medical University, where he developed a deep interest in pancreatic disease research. His postdoctoral studies further strengthened his expertise in surgical oncology, focusing on minimally invasive procedures and translational medicine. With a strong foundation in both clinical and academic research, he has cultivated a reputation for excellence in gastrointestinal and pancreatic surgery.

Experience

With years of clinical practice and research experience, Dr. Wang has played a pivotal role in advancing laparoscopic and minimally invasive surgical techniques. He has served as a principal investigator on numerous national and provincial research projects and has mentored numerous postgraduate students in the field of pancreatic disease. His leadership roles include Vice Chair positions in several prestigious medical committees, further demonstrating his influence in surgical oncology and digestive diseases. As a widely respected clinician, he has successfully performed complex surgical interventions, improving patient outcomes through precision and innovation.

Research Interests

Dr. Wang’s research is centered on the molecular mechanisms underlying pancreatic diseases, with a particular focus on acute pancreatitis and pancreatic cancer. His work has explored ferroptosis, necroptosis, mitochondrial autophagy, and exosomal miRNA-mediated cell communication in pancreatic pathology. His translational research bridges molecular discoveries with clinical applications, optimizing surgical protocols and therapeutic strategies to enhance patient survival rates and reduce postoperative complications.

Awards

Dr. Wang has been the recipient of several prestigious awards, including multiple Heilongjiang Science & Technology Progress First Prizes (2024, 2021). His innovative research contributions have earned him recognition as an Outstanding Talent of Heilongjiang New Century. He has been honored with more than 14 provincial and national awards, acknowledging his significant impact on pancreatic disease management and surgical advancements.

Publications

Wang G. et al. (2023). “Ferroptosis in Acute Pancreatitis: The Role of Nrf2-Beclin1-Slc7a11 Axis.” Journal of Pancreatic Research, cited by 150.

Wang G. et al. (2022). “Necroptosis and Pancreatic Inflammation: Insights from ATG7-miR-30b-5p/CAMKII Pathway.” Surgical Oncology Journal, cited by 120.

Wang G. et al. (2021). “Mitochondrial Autophagy Imbalance in Acute Pancreatitis: BCL2L1/FUNDC1 Pathway.” Digestive Surgery Research, cited by 110.

Wang G. et al. (2020). “Exosomal miRNA and Pancreatic Inflammation: Crosstalk Between Acinar Cells and Macrophages.” Translational Cancer Research, cited by 95.

Wang G. et al. (2019). “HIF-1α and Metabolic Reprogramming in Acute Pancreatitis.” World Journal of Gastroenterology, cited by 80.

Wang G. et al. (2018). “CHOP/PGAM5/Drp1: A Novel Pathway in Pancreatic Cell Death.” Journal of Clinical Gastroenterology, cited by 75.

Wang G. et al. (2017). “Innovative Surgical Strategies for Pancreatic Necrosis Management.” Journal of Hepatopancreatobiliary Surgery, cited by 60.

Conclusion

Based on his extensive research portfolio, high-impact publications, and numerous accolades, Professor Gang Wang is an exemplary candidate for the Best Researcher Award. His commitment to advancing knowledge in pancreatic diseases, innovative contributions to clinical practices, and leadership in the research community establish him as a leading figure in his field.

Sawsan A Mohammed | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Sawsan A Mohammed | AI in Healthcare | Best Researcher Award

Assistant Professor at Clinical Education Qatar University, Qatar

Dr. Sawsan Gholam A. A. Mohammed is a distinguished medical professional specializing in clinical education, rehabilitation medicine, and precision medicine. With a strong academic foundation and extensive research experience, she has contributed significantly to advancing medical knowledge, particularly in genomics, immunotherapy, and patient safety culture. Her dedication to medical research and education has earned her recognition as a thought leader in the field.

Profile

Orcid

Education

Dr. Mohammed completed her Medical Doctorate (PhD) at the University of Heidelberg in June 2019, where she conducted groundbreaking research in functional genome analysis. She obtained her Doctor of Medicine (M.D.) from the Arabian Gulf University, Bahrain, in December 1997, and earlier earned a Bachelor of Basic Medical Science (BBMS) from the same institution in April 1996. Her educational background has provided her with a strong foundation in both clinical and research-oriented medical sciences.

Experience

Dr. Mohammed currently serves as an Assistant Professor at the Clinical Academic Education Department at the College of Medicine, Doha, Qatar, where she has been shaping the next generation of medical professionals since January 2023. Additionally, she has been a Clinical Tutor in the same department since January 2022. Her research career includes her tenure as a doctoral student at the German Cancer Research Center from September 2014 to June 2019, where she explored functional genome analysis. Prior to that, she was a Guest Researcher in the Department of Clinical Chemistry at Heidelberg University Hospital from October 2011 to July 2014. Her clinical expertise spans multiple roles, including Clinical Associate at Rumailah Hospital’s Physical Medicine & Rehabilitation Department (2008–2011), Clinical Trainee at Danderyds Hospital, Karolinska Institute, Sweden (2003–2008), and Resident Physician at Rumailah Hospital (2001–2003). She also served as Acting Chief of the Speech Therapy Unit at Rumailah Hospital from 1999 to 2002.

Research Interests

Dr. Mohammed’s research interests are diverse and encompass precision medicine, biomedical informatics, genomic screening, and immunotherapy. She has contributed significantly to the understanding of how artificial intelligence can enhance medical practice and patient care. Her work also explores pharmacogenomics and its role in public health, particularly in Qatar. Additionally, she has a strong focus on maternal and neonatal health, autism-related neurodevelopmental disorders, and the integration of nutrition in medical treatment.

Awards and Recognitions

Dr. Mohammed has been recognized for her contributions to medical research and education through various awards and honors. She has participated in leadership and capacity-building programs, including the Leadership and Building Capacity Program at Qatar University (2023–2024). Her expertise has also been highlighted through invited talks, media interviews, and contributions to international medical publications. Her work in promoting women’s sports in Qatar and advocating for precision nutrition in autism care further demonstrate her multifaceted contributions to society.

Selected Publications

“Application of Proteomics in Maternal and Neonatal Health: Advancement and Future Directions,” FASEB Bioadvances, Feb. 2025.

“Holistic Precision Wellness: Paving the Way for Next-Generation Precision Medicine with AI,” Biomedical Informatics and Clinical Medicine, Feb. 2025.

“Ṯābit Ibn Qurrah’s Contributions to Toxicology,” Naunyn Schmiedebergs Arch Pharmacol, Aug. 2024.

“Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes,” MDPI Cancers, May 2024.

“Optimizing Cancer Therapy: A Review of Metronomic Chemotherapy,” Frontiers in Cell and Developmental Biology, May 2024.

“Forging the Path to Precision Medicine in Qatar: A Public Health Perspective on Pharmacogenomics,” Frontiers in Public Health, March 2024.

“Current Technologies and Future Perspectives in Immunotherapy toward a Clinical Oncology Approach,” MDPI Biomedicines, Jan. 2024.

Conclusion

Dr. Sawsan Mohammed is a dedicated academician, researcher, and clinician whose contributions to medicine have had a far-reaching impact. Her work in precision medicine, genomics, and clinical education continues to drive innovation in healthcare. As a mentor, she inspires future medical professionals, and as a researcher, she advances the boundaries of medical science. Through her interdisciplinary approach and commitment to improving patient care, she remains a vital contributor to the global medical community.